Skip to content

Clinical trials

Completed Phase 2 Bone Diseases, Metabolic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Phase 2 Status: Completed Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20045
20061
20073
20081
20092
20101
20115
20121
20132
20142
20153
20191
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Northwestern University4
Children's Hospital Medical Center, Cincinnati2
Massachusetts General Hospital2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Alexandria University1
BioActor1
Columbia University1
Creighton University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic38
Osteoporosis26
Bone Diseases8
Musculoskeletal Diseases6
Osteoporosis, Postmenopausal5
Spinal Cord Injuries5
Fractures, Bone4
Spinal Cord Diseases4
Central Nervous System Diseases3
Nervous System Diseases3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.